Comparing the feasibility and safety of Intrathecal administration of nusinersen via interlaminar or transforaminal approach in adult and adolescent patients with Spinal Muscular Atrophy and Scoliosis
Latest Information Update: 08 Sep 2020
At a glance
- Drugs Nusinersen (Primary)
- Indications Spinal muscular atrophy
- Focus Adverse reactions; Therapeutic Use
- 08 Sep 2020 New trial record